Non-coding RNAs-Novel targets in neurotoxicity

NeuroToxicology

Volumn 33, Issue 3, 2012, Pages 530-544

  Tal, Tamara L ^a   Tanguay, Robert L ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

MicroRNAs; NcRNAs; Neurotoxicology

Indexed keywords

ACICLOVIR; ALCOHOL; ALUMINUM; CELL NUCLEUS RECEPTOR; CISPLATIN; COCAINE; CYCLONITE; CYTOCHROME P450; DEXAMETHASONE; FENTANYL; FLUOXETINE; IRON; LITHIUM; MICRORNA; MICRORNA 132; MICRORNA 29A; MICRORNA 29B; MITOMYCIN C; MORPHINE; NEUROTOXIN; NICOTINE; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PESTICIDE; RETINOID X RECEPTOR ALPHA; SEROTONIN UPTAKE INHIBITOR; TEMOZOLOMIDE; UNINDEXED DRUG; UNTRANSLATED RNA; VALPROIC ACID;

BIOGENESIS; DENDRITIC CELL; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; GENETIC REGULATION; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA STABILITY; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEUROLOGY; NEURONS; NEUROTOXICITY SYNDROMES; RISK ASSESSMENT; RISK FACTORS; RNA, SMALL UNTRANSLATED; TOXICOLOGY; TRANSCRIPTION, GENETIC;

EID: 84861188552     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.02.013     Document Type: Review

References (128)

1. Alliey-Rodriguez N., Zhang D., Badner J.A., Lahey B.B., Zhang X., Dinwiddie S., et al. Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet 2011, 21:190-194.
2. Aravin A.A., Hannon G.J., Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science 2007, 318:761-764.
3. Au P.C., Zhu Q.H., Dennis E.S., Wang M.B. Long non-coding RNA-mediated mechanisms independent of the RNAi pathway in animals and plants. RNA Biol 2011, 8:404-414.
4. Barbee S.A., Estes P.S., Cziko A.M., Hillebrand J., Luedeman R.A., Coller J.M., et al. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 2006, 52:997-1009.
5. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
6. Bejerano G., Pheasant M., Makunin I., Stephen S., Kent W.J., Mattick J.S., et al. Ultraconserved elements in the human genome. Science 2004, 304:1321-1325.
7. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 2002, 22:6766-6772.
8. Bondy S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31:575-581.
9. Bourne J.N., Harris K.M. Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci 2008, 31:47-67.
10. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol 2005, 3:e85.
11. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65:6029-6033.
12. Chatterjee S., Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009, 461:546-549.
13. Corcoran D.L., Pandit K.V., Gordon B., Bhattacharjee A., Kaminski N., Benos P.V. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PloS One 2009, 4:e5279.
14. Cougot N., Bhattacharyya S.N., Tapia-Arancibia L., Bordonne R., Filipowicz W., Bertrand E., et al. Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J Neurosci 2008, 28:13793-13804.
15. Cowmeadow R.B., Krishnan H.R., Atkinson N.S. The slowpoke gene is necessary for rapid ethanol tolerance in Drosophila. Alcohol Clin Exp Res 2005, 29:1777-1786.
16. Davies A.G., Pierce-Shimomura J.T., Kim H., VanHoven M.K., Thiele T.R., Bonci A., et al. A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 2003, 115:655-666.
17. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci 2008, 28:4322-4330.
18. De Pietri Tonelli D., Pulvers J.N., Haffner C., Murchison E.P., Hannon G.J., Huttner W.B. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 2008, 135:3911-3921.
19. Derrien T., Guigo R., Johnson R. The long non-coding RNAs: a new (P)layer in the dark matter. Front Genet 2011, 2:107.
20. Du T., Zamore P.D. microPrimer: the biogenesis and function of microRNA. Development 2005, 132:4645-4652.
21. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
22. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
23. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008, 14:723-730.
24. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
25. Gao F.B. Context-dependent functions of specific microRNAs in neuronal development. Neural Dev 2010, 5:25.
26. Gehrke S., Imai Y., Sokol N., Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
27. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009, 10:94-108.
28. Giraldez A.J., Cinalli R.M., Glasner M.E., Enright A.J., Thomson J.M., Baskerville S., et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005, 308:833-838.
29. Gopinath S.C., Matsugami A., Katahira M., Kumar P.K. Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res 2005, 33:4874-4881.
30. Gopinath S.C., Wadhwa R., Kumar P.K. Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance. Mol Cancer Res 2010, 8:1536-1546.
31. Grosshans H., Chatterjee S. MicroRNAses and the regulated degradation of mature animal miRNAs. Adv Exp Med Biol 2010, 700:140-155.
32. Guengerich F.P. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008, 21:70-83.
33. Hamilton A.J., Baulcombe D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999, 286:950-952.
34. Hansen K.F., Sakamoto K., Wayman G.A., Impey S., Obrietan K. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PloS One 2010, 5:e15497.
35. Hebert S.S., Papadopoulou A.S., Smith P., Galas M.C., Planel E., Silahtaroglu A.N., et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 2010, 19:3959-3969.
36. Hinske L.C., Galante P.A., Kuo W.P., Ohno-Machado L. A potential role for intragenic miRNAs on their hosts' interactome. BMC Genomics 2010, 11:533.
37. Hollander J.A., Im H.I., Amelio A.L., Kocerha J., Bali P., Lu Q., et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010, 466:197-202.
38. Huang T., Liu Y., Huang M., Zhao X., Cheng L. Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice. J Mol Cell Biol 2010, 2:152-163.
39. *, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol 2009, 12:537-546.
40. Im H.I., Hollander J.A., Bali P., Kenny P.J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010, 13:1120-1127.
41. Impey S., Davare M., Lasiek A., Fortin D., Ando H., Varlamova O., et al. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol Cell Neurosci 2010, 43:146-156.
42. Jacobsen A., Wen J., Marks D.S., Krogh A. Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res 2010, 20:1010-1019.
43. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
44. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol 2007, 8:R173.
45. Kawashima H., Numakawa T., Kumamaru E., Adachi N., Mizuno H., Ninomiya M., et al. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience 2010, 165:1301-1311.
46. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
47. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005, 6:376-385.
48. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139.
49. Kiss-Laszlo Z., Henry Y., Bachellerie J.P., Caizergues-Ferrer M., Kiss T. Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs. Cell 1996, 85:1077-1088.
50. Klann E., Dever T.E. Biochemical mechanisms for translational regulation in synaptic plasticity. Nat Rev Neurosci 2004, 5:931-942.
51. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., Huang J., Ramsey A.J., Caron M.G., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A 2009, 106:3507-3512.
52. Korosi A., Naninck E.F., Oomen C.A., Schouten M., Krugers H., Fitzsimons C., et al. Early-life stress mediated modulation of adult neurogenesis and behavior. Behav Brain Res 2012, 227:400-409.
53. Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9:1274-1281.
54. Krol J., Busskamp V., Markiewicz I., Stadler M.B., Ribi S., Richter J., et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010, 141:618-631.
55. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
56. Kumamaru E., Numakawa T., Adachi N., Yagasaki Y., Izumi A., Niyaz M., et al. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 2008, 22:546-558.
57. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
58. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
59. Lau P., de Strooper B. Dysregulated microRNAs in neurodegenerative disorders. Semin Cell Dev Biol 2010, 21:768-773.
60. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
61. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
62. Li X., Jin P. Macro role(s) of microRNAs in fragile X syndrome?. Neuromolecular Med 2009, 11:200-207.
63. Ling S.C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A 2010, 107:13318-13323.
64. Lippi G., Steinert J.R., Marczylo E.L., D'Oro S., Fiore R., Forsythe I.D., et al. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol 2011, 194:889-904.
65. Lugli G., Larson J., Martone M.E., Jones Y., Smalheiser N.R. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J Neurochem 2005, 94:896-905.
66. Lukiw W.J., Cui J.G., Yuan L.Y., Bhattacharjee P.S., Corkern M., Clement C., et al. Acyclovir or Abeta42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport 2010, 21:922-927.
67. Lukiw W.J., Pogue A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 2007, 101:1265-1269.
68. Lukiw W.J., Zhao Y., Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 2008, 283:31315-31322.
69. Ma J., Murphy M., O'Dwyer P.J., Berman E., Reed K., Gallo J.M. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochem Pharmacol 2002, 63:1219-1228.
70. Magill S.T., Cambronne X.A., Luikart B.W., Lioy D.T., Leighton B.H., Westbrook G.L., et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A 2010, 107:20382-20387.
71. Mattick J.S. RNA regulation: a new genetics?. Nat Rev Genet 2004, 5:316-323.
72. Mellios N., Huang H.S., Grigorenko A., Rogaev E., Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 2008, 17:3030-3042.
73. Meng F., Henson R., Lang M., Wehbe H., Maheshwari S., Mendell J.T., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130:2113-2129.
74. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10:155-159.
75. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008, 283:29897-29903.
76. Murer M.G., Yan Q., Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001, 63:71-124.
77. Nakajima, M., Yokoi, T., 2011. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol Ther.
78. Nelson P.T., Wang W.X. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis 2010, 21:75-79.
79. Pan Y.Z., Gao W., Yu A.M. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 2009, 37:2112-2117.
80. Parker R., Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007, 25:635-646.
81. Persson H., Kvist A., Vallon-Christersson J., Medstrand P., Borg A., Rovira C. The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs. Nat Cell Biol 2009, 11:1268-1271.
82. Pietrzykowski A.Z., Friesen R.M., Martin G.E., Puig S.I., Nowak C.L., Wynne P.M., et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008, 59:274-287.
83. Pinter R., Hindges R. Perturbations of microRNA function in mouse dicer mutants produce retinal defects and lead to aberrant axon pathfinding at the optic chiasm. PloS One 2010, 5:e10021.
84. Pogue A.I., Li Y.Y., Cui J.G., Zhao Y., Kruck T.P., Percy M.E., et al. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem 2009, 103:1591-1595.
85. Pogue A.I., Percy M.E., Cui J.G., Li Y.Y., Bhattacharjee S., Hill J.M., et al. Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J Inorg Biochem 2011, 105:1434-1437.
86. Preker P., Nielsen J., Kammler S., Lykke-Andersen S., Christensen M.S., Mapendano C.K., et al. RNA exosome depletion reveals transcription upstream of active human promoters. Science 2008, 322:1851-1854.
87. Remenyi J., Hunter C.J., Cole C., Ando H., Impey S., Monk C.E., et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010, 428:281-291.
88. Ren Y., Zhou X., Mei M., Yuan X.B., Han L., Wang G.X., et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010, 10:27.
89. Rom S., Rom I., Passiatore G., Pacifici M., Radhakrishnan S., Del Valle L., et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 2010, 24:2292-2300.
90. Roos W.P., Batista L.F., Naumann S.C., Wick W., Weller M., Menck C.F., et al. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007, 26:186-197.
91. Sanchez-Simon F.M., Zhang X.X., Loh H.H., Law P.Y., Rodriguez R.E. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol 2010, 78:935-942.
92. Santillano D.R., Kumar L.S., Prock T.L., Camarillo C., Tingling J.D., Miranda R.C. Ethanol induces cell-cycle activity and reduces stem cell diversity to alter both regenerative capacity and differentiation potential of cerebral cortical neuroepithelial precursors. BMC Neurosci 2005, 6:59.
93. Sathyan P., Golden H.B., Miranda R.C. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 2007, 27:8546-8557.
94. Schaefer A., Im H.I., Veno M.T., Fowler C.D., Min A., Intrator A., et al. Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med 2010, 207:1843-1851.
95. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., et al. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007, 204:1553-1558.
96. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
97. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., et al. Divergent transcription from active promoters. Science 2008, 322:1849-1851.
98. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009, 459:100-104.
99. Shi L., Chen J., Yang J., Pan T., Zhang S., Wang Z. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 2010, 1352:255-264.
100. Siegel G., Obernosterer G., Fiore R., Oehmen M., Bicker S., Christensen M., et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009, 11:705-716.
101. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Annu Rev Microbiol 2010, 64:123-141.
102. Smalheiser N.R., Lugli G. microRNA regulation of synaptic plasticity. Neuromolecular Med 2009, 11:133-140.
103. Smillie K.J., Cousin M.A. Dynamin I phosphorylation and the control of synaptic vesicle endocytosis. Biochem Soc Symp 2005, 87-97.
104. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 2008, 40:751-760.
105. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
106. Taft R.J., Glazov E.A., Cloonan N., Simons C., Stephen S., Faulkner G.J., et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet 2009, 41:572-578.
107. Taft R.J., Pheasant M., Mattick J.S. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 2007, 29:288-299.
108. Takagi S., Nakajima M., Mohri T., Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 2008, 283:9674-9680.
109. Tal T.L., Franzosa J.A., Tilton S.C., Philbrick K.A., Iwaniec U.T., Turner R.T., et al. MicroRNAs control neurobehavioral development and function in zebrafish. FASEB J 2012.
110. Treistman S.N., Martin G.E. BK Channels: mediators and models for alcohol tolerance. Trends Neurosci 2009, 32:629-637.
111. Tsang J., Zhu J., van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 2007, 26:753-767.
112. Ueda H., Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence. Front Biosci 2009, 14:5260-5272.
113. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
114. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 2005, 102:16426-16431.
115. Vreugdenhil E., Verissimo C.S., Mariman R., Kamphorst J.T., Barbosa J.S., Zweers T., et al. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150:2220-2228.
116. Wang X., Zhou S., Ding X., Zhu G., Guo J. Effect of triazophos, fipronil and their mixture on miRNA expression in adult zebrafish. J Environ Sci Health B 2010, 45:648-657.
117. Wayman G.A., Davare M., Ando H., Fortin D., Varlamova O., Cheng H.Y., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A 2008, 105:9093-9098.
118. Weeraratne S.D., Amani V., Neiss A., Teider N., Scott D.K., Pomeroy S.L., et al. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol 2011, 13:165-175.
119. Williams L.R., Aroniadou-Anderjaska V., Qashu F., Finne H., Pidoplichko V., Bannon D.I., et al. RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environ Health Perspect 2011, 119:357-363.
120. Wu Q., Zhang L., Law P.Y., Wei L.N., Loh H.H. Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol 2009, 75:744-750.
121. Wu X., Song Y. Preferential regulation of miRNA targets by environmental chemicals in the human genome. BMC Genomics 2011, 12:244.
122. Xu Q., Huang W., Payne T.J., Ma J.Z., Li M.D. Detection of genetic association and a functional polymorphism of dynamin 1 gene with nicotine dependence in European and African Americans. Neuropsychopharmacology 2009, 34:1351-1359.
123. Xu Q., Li M.D. Nicotine modulates expression of dynamin 1 in rat brain and SH-SY5Y cells. Neurosci Lett 2011, 489:168-171.
124. Yu A.M. Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 2009, 5:1513-1528.
125. Zehir A., Hua L.L., Maska E.L., Morikawa Y., Cserjesi P. Dicer is required for survival of differentiating neural crest cells. Dev Biol 2010, 340:459-467.
126. Zhang B., Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect 2009, 117:231-240.
127. Zheng H., Zeng Y., Zhang X., Chu J., Loh H.H., Law P.Y. mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol 2010, 77:102-109.
128. Zhou R., Yuan P., Wang Y., Hunsberger J.G., Elkahloun A., Wei Y., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.